Our BioID2-based proximity labeling approach also revealed several other EMP3-proximal proteins, including GBM-relevant membrane receptors (e.g., CD44, integrins, SLCs), signaling adaptors, and other trafficking regulators. The gene discussed is CD44; the disease is glioblastoma.